Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Mepolizumab> ?p ?o }
Showing triples 1 to 74 of
74
with 100 triples per page.
- Mepolizumab abstract "Mepolizumab (trade name Nucala) is a humanized monoclonal antibody that recognizes interleukin-5 (IL-5).Mepolizumab has been investigated or is under investigation for the treatment of severe eosinophilic asthma, atopic dermatitis, hypereosinophilic syndrome (HES), eosinophilic esophagitis (EoE), nasal polyposis, eosinophilic granulomatosis with polyangiitis (EGPA) (i.e., Churg Strauss syndrome), and chronic obstructive pulmonary disease (COPD). Phase III clinical trials in severe eosinophilic asthma were completed in 2014.Mepolizumab is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of severe asthma in patients aged 12 years or older and with an eosinophilic phenotype in combination with other medicines used to treat asthma.The European Commission granted a marketing authorisation valid throughout the European Union on 2 December 2015. In Europe Nucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adult patients.".
- Mepolizumab atcPrefix "L04".
- Mepolizumab atcSuffix "AC06".
- Mepolizumab casNumber "196078-29-2".
- Mepolizumab drugbank "DB06612".
- Mepolizumab fdaUniiCode "90Z2UF0E52".
- Mepolizumab wikiPageID "9412572".
- Mepolizumab wikiPageLength "2706".
- Mepolizumab wikiPageOutDegree "16".
- Mepolizumab wikiPageRevisionID "699472323".
- Mepolizumab wikiPageWikiLink Asthma.
- Mepolizumab wikiPageWikiLink Atopic_dermatitis.
- Mepolizumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Mepolizumab wikiPageWikiLink Chronic_obstructive_pulmonary_disease.
- Mepolizumab wikiPageWikiLink Churg–Strauss_syndrome.
- Mepolizumab wikiPageWikiLink Eosinophilic_esophagitis.
- Mepolizumab wikiPageWikiLink European_Commission.
- Mepolizumab wikiPageWikiLink European_Union.
- Mepolizumab wikiPageWikiLink Food_and_Drug_Administration.
- Mepolizumab wikiPageWikiLink Humanized_antibody.
- Mepolizumab wikiPageWikiLink Hypereosinophilic_syndrome.
- Mepolizumab wikiPageWikiLink Interleukin_5.
- Mepolizumab wikiPageWikiLink Monoclonal_antibody.
- Mepolizumab wikiPageWikiLink Nasal_polyp.
- Mepolizumab wikiPageWikiLinkText "Bosatria".
- Mepolizumab wikiPageWikiLinkText "Mepolizumab".
- Mepolizumab wikiPageWikiLinkText "mepolizumab".
- Mepolizumab atcPrefix "L04".
- Mepolizumab atcSuffix "AC06".
- Mepolizumab casNumber "196078".
- Mepolizumab chemspiderid "none".
- Mepolizumab drugbank "DB06612".
- Mepolizumab eliminationHalfLife "1728000.0".
- Mepolizumab kegg "D04923".
- Mepolizumab mabType "mab".
- Mepolizumab pubchemsubstance "47206675".
- Mepolizumab source "zu/o".
- Mepolizumab target Interleukin_5.
- Mepolizumab tradename "Nucala".
- Mepolizumab type "mab".
- Mepolizumab unii "90".
- Mepolizumab verifiedfields "changed".
- Mepolizumab verifiedrevid "462248575".
- Mepolizumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Mepolizumab wikiPageUsesTemplate Template:Cascite.
- Mepolizumab wikiPageUsesTemplate Template:Chemspidercite.
- Mepolizumab wikiPageUsesTemplate Template:Drugbankcite.
- Mepolizumab wikiPageUsesTemplate Template:Drugbox.
- Mepolizumab wikiPageUsesTemplate Template:Drugs.com.
- Mepolizumab wikiPageUsesTemplate Template:Keggcite.
- Mepolizumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Mepolizumab wikiPageUsesTemplate Template:Reflist.
- Mepolizumab wikiPageUsesTemplate Template:Respiratory-system-drug-stub.
- Mepolizumab subject Category:Monoclonal_antibodies.
- Mepolizumab hypernym Antibody.
- Mepolizumab type ChemicalSubstance.
- Mepolizumab type Drug.
- Mepolizumab type Antibody.
- Mepolizumab type Chemical.
- Mepolizumab type Drug.
- Mepolizumab type Immunosuppressant.
- Mepolizumab type Redirect.
- Mepolizumab type ChemicalObject.
- Mepolizumab type Thing.
- Mepolizumab type Q8386.
- Mepolizumab comment "Mepolizumab (trade name Nucala) is a humanized monoclonal antibody that recognizes interleukin-5 (IL-5).Mepolizumab has been investigated or is under investigation for the treatment of severe eosinophilic asthma, atopic dermatitis, hypereosinophilic syndrome (HES), eosinophilic esophagitis (EoE), nasal polyposis, eosinophilic granulomatosis with polyangiitis (EGPA) (i.e., Churg Strauss syndrome), and chronic obstructive pulmonary disease (COPD).".
- Mepolizumab label "Mepolizumab".
- Mepolizumab sameAs Q3306175.
- Mepolizumab sameAs ميبوليزوماب.
- Mepolizumab sameAs Mepolizumab.
- Mepolizumab sameAs m.0287vp9.
- Mepolizumab sameAs Q3306175.
- Mepolizumab wasDerivedFrom Mepolizumab?oldid=699472323.
- Mepolizumab isPrimaryTopicOf Mepolizumab.